Octaplas Side Effects
Generic name: plasma protein fraction
Medically reviewed by Drugs.com. Last updated on Jul 22, 2020.
Note: This document contains side effect information about plasma protein fraction. Some of the dosage forms listed on this page may not apply to the brand name Octaplas.
For the Consumer
Applies to plasma protein fraction: parenteral solution for injection
Side effects include:
For Healthcare Professionals
Applies to plasma protein fraction: intravenous solution
Frequency not reported: Severe hypotension, chest pain, chest discomfort[Ref]
Common (1% to 10%): Urticaria, pruritus
Uncommon (0.1% to 1%): Nausea, vomiting
Very rare (less than 0.01%): Back pain[Ref]
Uncommon (0.1% to 1%): Hypoesthesia
Very rare (less than 0.01%): Dizziness, paresthesia
Frequency not reported: Headache[Ref]
Very rare (less than 0.01%): Hemolytic anemia, hemorrhagic diathesis, citrate toxicity
Frequency not reported: Hyperfibrinolysis[Ref]
Uncommon (0.1% to 1%): Anaphylaxis
Rare (less than 0.1%): Hypersensitivity[Ref]
Very rare (less than 0.01%): Application site reaction[Ref]
Uncommon (0.1% to 1%): Hypoxia
Frequency not reported: Tachypnea[Ref]
Uncommon (0.1% to 1%): Pyrexia
1. "Product Information. Plasmanate (plasma protein fraction)." Bayer Pharmaceutical Inc, West Haven, CT.
2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
More about Octaplas (plasma protein fraction)
Related treatment guides
Some side effects may not be reported. You may report them to the FDA.